Business
Veru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. Public Health Sector
MIAMI, FL, April 19, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and
About this update from Veru Inc.
[{"type":"text","content":"MIAMI, FL, April 19, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related diseases that has a commercial sexual health division, today announced it has entered into a Purchasing Agreement with Afaxys Group Services, LLC (AGS) to offer Veru’s FC2 Female Condom® (internal condom) through the AGS Group Purchasing Organization (GPO) for the benefit of up to 31 million women and men that depend on community and public health centers for essential healthcare. Afaxys is a trusted, mission-driven healthcare company that uniquely partners with those who serve community and public health patients to ensure access to affordable sexual and reproductive healthcare. Under the terms of the agreement, Afaxys members will have access to a preferred pricing model for Veru’s FC2 Female Condom®, an FDA-approved method of contraception indicated for preventing pregnancy and the transmission of sexually transmitted infections, including HIV/AIDS. As a result, Afaxys’ healthcare provider membership is guaranteed reliable and affordable access to the FC2 Female Condom® for their patients. “We applaud Afaxys for growing its portfolio of contraceptive product offerings with the addition of a non-hormonal contraceptive method, the FC2 Female Condom,” said Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer of Veru. “This partnership will bring affordability and accessibility to family planning clinics, community health centers, and qualified private practices serving underrepresented women, an important and large U.S. public sector channel.” “As a socially conscious company, Afaxys ensures affordable access to sexual and reproductive healthcare is a right, not a privilege, for all patients,” said Angela Hensel, Executive Director Afaxys Group Services. “We are proud to collaborate with Veru to help ensure this unique contraceptive option is available to meet the needs of our Afaxys GPO members.” The FC2 Female Condom® telehealth portal is available at www.fc2condoms.com. Pharmacists can order FC2 Female Condom from major wholesale distributors. About FC2 Female Condom® (internal condom) The FC2 Female Condom® (internal condom) is the only FDA-approved birth control option that protects against unintended pregnancy a...